Methods of treatment and pharmaceutical compositions using bcn057 or bcn512
AssigneeBCN Biosciences L.L.C.
InventorAndrew J. Norris
Life of this patent
Estimating the term…
Abstract
The present disclosure is directed to method of treatment for treating or ameliorating various conditions pertaining such as bone marrow recovery (or blood cell production), fibrosis, inflammatory diseases, inhibition of cancer cell growth, propagation or malignancy, thrombocytopenia, wound healing, and conditions related to stem cells by the administration of BCN057, 512, or an analog thereof.
Claims14
A method of improving wound and tissue healing in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of BCN057, BCN512 or an analog thereof.
A method of preventing late effects of clinical radiation, the method comprising administering to the subject a therapeutically effective amount of BCN057, BCN512 or an analog thereof, wherein the effects are reduction of tissue fibrosis, reduction in hormonal deficits, reduction in neurological impairment from radiation, reduction in growth retardation from radiation treatment, reduction of pulmonary, prostate, colon or kidney damage from radiation, reduction in leukemia arising from radiation treatment.
A method of treating fibrosis in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of BCN057, BCN512, or an analog thereof.
Dependencies are inferred from the claim text.